Skinive
1 known investors
Skinive develops CE-marked medical software that uses AI to screen and analyze skin for moles, rashes, acne, eczema, and 55+ other skin conditions. It serves individuals, clinicians, and developers, offering self-check apps, clinical assessment tools including 3D full-body mole mapping, and AI skin analysis that can be integrated into telemedicine and beauty applications.